(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.92%) $83.08
(-1.16%) $1.619
(-0.37%) $2 338.60
(-0.07%) $27.52
(0.53%) $927.00
(-0.17%) $0.933
(-0.16%) $11.01
(-0.26%) $0.798
(0.00%) $92.17
Live Chart Being Loaded With Signals
Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas...
Stats | |
---|---|
本日の出来高 | 1.76M |
平均出来高 | 5.23M |
時価総額 | 0.00 |
EPS | $-0.0100 ( 2022-05-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 14.95 |
ATR14 | $0.104 (1.86%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-05-24 | Gueth Anton | Sell | 79 645 | Common Stock |
2022-05-24 | Gueth Anton | Sell | 61 930 | Stock Option (right to buy) |
2022-05-24 | Gueth Anton | Sell | 99 395 | Stock Option (right to buy) |
2022-05-24 | Gueth Anton | Sell | 150 000 | Stock Option (right to buy) |
2022-05-24 | Gueth Anton | Sell | 80 318 | Stock Option (right to buy) |
INSIDER POWER |
---|
-100.00 |
Last 97 transactions |
Buy: 1 667 582 | Sell: 3 999 780 |
ボリューム 相関
Antares Pharma Inc 相関
10 最も負の相関 | |
---|---|
CHDN | -0.971 |
CFBK | -0.968 |
HURC | -0.965 |
PEAR | -0.951 |
AGIL | -0.951 |
GRNA | -0.95 |
VRAY | -0.948 |
PROC | -0.947 |
SNGX | -0.946 |
VWE | -0.942 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Antares Pharma Inc 相関 - 通貨/商品
Antares Pharma Inc 財務諸表
Annual | 2021 |
収益: | $183.98M |
総利益: | $115.70M (62.89 %) |
EPS: | $0.280 |
FY | 2021 |
収益: | $183.98M |
総利益: | $115.70M (62.89 %) |
EPS: | $0.280 |
FY | 2020 |
収益: | $149.60M |
総利益: | $86.50M (57.82 %) |
EPS: | $0.340 |
FY | 2019 |
収益: | $123.86M |
総利益: | $73.39M (59.25 %) |
EPS: | $-0.0100 |
Financial Reports:
No articles found.
Antares Pharma Inc
Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto-injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto-injectors; TLANDO to treat deficiency or absence of endogenous testosterone in adult males; and drug/device products for urologic oncology, immunology, and endocrinology. The company has strategic alliances and partnerships with Pfizer Inc., Idorsia Pharmaceuticals Ltd, Teva Pharmaceutical Industries, Ltd, and AMAG. Antares Pharma, Inc. was incorporated in 1979 and is headquartered in Ewing, New Jersey. As of May 23, 2022, Antares Pharma, Inc. operates as a subsidiary of Halozyme Therapeutics, Inc.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。